<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR22">
 <label>22.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rifkin</surname>
    <given-names>RM</given-names>
   </name>
   <name>
    <surname>Abonour</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Shah</surname>
    <given-names>JJ</given-names>
   </name>
   <name>
    <surname>Mehta</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Narang</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Terebelo</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Gasparetto</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Toomey</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Hardin</surname>
    <given-names>JW</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>JJ</given-names>
   </name>
   <name>
    <surname>Kenvin</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Srinivasan</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Knight</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Nagarwala</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Durie</surname>
    <given-names>BG</given-names>
   </name>
  </person-group>
  <article-title>Connect MM(R) - the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide</article-title>
  <source>Leuk Lymphoma</source>
  <year>2016</year>
  <volume>57</volume>
  <issue>9</issue>
  <fpage>2228</fpage>
  <lpage>2231</lpage>
  <pub-id pub-id-type="doi">10.3109/10428194.2015.1132419</pub-id>
  <?supplied-pmid 26766599?>
  <pub-id pub-id-type="pmid">26766599</pub-id>
 </element-citation>
</ref>
